Trial Profile
Nintedanib Plus Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Phase 0/1 Safety and Pharmacodynamics
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Nintedanib (Primary) ; Letrozole
- Indications Early breast cancer
- Focus Adverse reactions; Pharmacodynamics
- 22 Jul 2019 Status changed from recruiting to completed.
- 13 Sep 2017 Planned End Date changed from 1 Dec 2017 to 1 Apr 2018.
- 13 Sep 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Oct 2017.